The Russian vaccine created at the Gamaleya Research Centre in Moscow is being rolled out internationally in the race to control the ongoing COVID-19 pandemic, the chief executive of Russia’s sovereign wealth fund said on Thursday.
The Russian Direct Investment Fund (RDIF) plans to expand its operations and increase the rollout of Russia’s Sputnik V vaccine across the globe amid the ongoing COVID-19 pandemic, RDIF Chief Executive Kirill Dmitriev said at the REUTERS NEXT Summit on Thursday.